| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.42 | 3e-14 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.41 | 9e-14 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.095 | 0.1 |